Patrick B. Mark

Medicine · Health Sciences

67h-index16.6kcitations546works4.82yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Kidney Disease and Diabetes(99), Dialysis and Renal Disease Management(96), Renal and Vascular Pathologies(59), Diabetes Treatment and Management(52), Blood Pressure and Hypertension Studies(46)

Publications524 total

Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) Trial
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)·2026Open Access
Adjudicating heart failure as an end point in dialysis
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)·2025Open Access
Sex differences in cardiac risk and kidney function: serum creatinine versus cystatin C
BMC Medicine·2025Open Access
Treatment burden and health literacy among patients referred to a vascular access clinic: a cross-sectional study
BMC Nephrology·2025Open Access
The kidney failure risk equation in people with CKD and multimorbidity: the effect of competing mortality risks
Nephrology Dialysis Transplantation·2025Open Access
Discordance in Creatinine- and Cystatin C–Based eGFR and Clinical Outcomes
JAMA·2025· 1 citedOpen Access
New kidneys, old risks: cardiovascular challenges after transplantation
Nephrology Dialysis Transplantation·2025· 1 citedOpen Access
Proteinuria or Albuminuria as Markers of Kidney and Cardiovascular Disease Risk
Annals of Internal Medicine·2025Open Access
Evidence for the efficacy of phosphate binders for preventing CKD complications was mostly low to very low certainty
Annals of Internal Medicine·2025Open Access
Balcinrenone in combination with dapagliflozin compared with dapagliflozin alone in patients with chronic kidney disease and albuminuria: a randomised, active-controlled double-blind, phase 2b clinical trial
The Lancet·2025· 4 citedOpen Access
Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023
The Lancet·2025· 29 citedOpen Access
Low circulating miR-190a-5p predicts progression of chronic kidney disease
Nature Communications·2025Open Access
Providing Affordable, Patient-Centered Care: Building Patient Satisfaction in a Student-Run Athletic Training Clinic
Journal of Athletic Training Education and Practice·2025
<b>Dickkopf-3 (DKK3) </b><b>and the progression of diabetic kidney disease</b><b>in primary health care</b>
2025Open Access
<b>Dickkopf-3 (DKK3) </b><b>and the progression of diabetic kidney disease</b><b>in primary health care</b>
2025Open Access
Healthcare workload associated with transition onto kidney replacement therapy: a retrospective cohort study
2025Open Access
Dickkopf-3 (DKK3) and the Progression of Diabetic Kidney Disease in Primary Health Care
Diabetes·2025· 4 citedOpen Access
Efficacy and Safety of Balcinrenone in Combination with Dapagliflozin on Albuminuria in Participants with CKD
Journal of the American Society of Nephrology·2025
#1005 Cardio-renal outcomes over time following immune checkpoint inhibitor therapy: a single centre retrospective analysis
Nephrology Dialysis Transplantation·2025Open Access
#117 Patients’ perspectives on the use of the kidney failure risk equation and shared decision making in multimorbidity and frailty: a qualitative interview study
Nephrology Dialysis Transplantation·2025Open Access
page 1 of 27Next →

Frequent Co-authors

Alan G. Jardine(17), Paul Welsh(9), Naveed Sattar(9), Henry J. Dargie(9), David C. Wheeler(7), Philip A. Kalra(7), Charles J. Ferro(6), Roberto Pecoits‐Filho(6), Patrick Rossignol(6), John J.V. McMurray(6), John G.F. Cleland(6), Jill P. Pell(6), Charles A. Herzog(5), Michael Cheung(5), Pardeep S. Jhund(5), Manish M. Sood(5), Claire Welsh(5), Carlos Celis‐Morales(5), James Lewsey(5), Stuart R. Gray(5)